Table 5.
Comparison of case-control studies of plasma amino acids in children with ASD
Author (country/region; race; publication year; journal) | ASD group n(male/female;age(M ± SD) | Control group n(male/female;age(M ± SD) | Diagnostic criteria(ASD) | Types of Sample | Detection method | amino acids (AAs) outcomes | Cognition(DQ/IQ) | Severity of autism | Regression | Others | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Adams JB et al. (America/Arizona; Nil; 2011; Nutrition & Metabolism) |
55(49/6; 10 ± 3.1y) | 44(39/5; 11 ± 3.1y) | DSM-IV | Plasma | HPLC-MS/MS |
Forty one plasma AAs measured. 1. ASD group: 1) Increased level: glutamate, serine, beta-amino isobutyrate, and homocysteine. 2) Decreased level: tryptophan, isoleucine, phenylalanine, tyrosine, and taurine. 2. Severity of autism: The proline, serine, ethanolamine, or beta-amino-isobutyrate correlated with the severity of autism for all three scales (PDD-BI/ATEC/SAS). |
Nil | PDD-BI/ATEC/SAS | Nil |
1. Fasting for 8-12 h. 2. Sex-age matched. 3. Children’ age 5–16 years old in both groups. 4. No usage of a vitamin/mineral supplement in the last 2 Mo. 5. No current use of any chelation treatment. 6. 20 out of 41 plasma AAs below the detection limit. |
|||
2. Naushad SM et al. (India/Hyderabad; Nil;2013; Indian Journal of Biochemistry & Biophysis) | 138(120/18; 4.4 ± 1.7y) | 138(120/18; 4.4 ± 1.6y) | DSM-IV/ABC | Plasma | Reverse-phase HPLC |
Ten plasma AAs tested. ASD group: 1) Increased level: glutamate, and asparagine. 2) Decreased: tryptophan, histidine, methionine, and phenylalanine. |
DQ (ASD group: 30 < DQ < 80/control group: DQ > 80) | Nil | Nil |
1. No special diet during the time of analysis. 2. Fasting blood samples. 3. ABC score: ASD group >68 score; Control group<21score. 4. Sex-age matched. |
|||
3. Cai J et al. (China /Shangdong; Han; 2016;NeuroReport) | 51(42/9; average age:3.69y) |
Healthy control: 51(42/9; average age :3.69y); ID group: 51(42/9; average age :3.69y) |
DSM-IV | Plasma | LC-MS/MS |
Only detected glutamate. 1. ASD group: Increased level: glutamate. 2. Severity of autism: The increased level of glutamate positively associated with severity of autism. |
Average FSIQ (ASD /control/ID group): 72.6/102 /68.7 |
Average CARS score (ASD/control/ID group): 41.1/21.8 /22.5 | Nil |
1. Medication free for at least 5 weeks. 2. BMI (ASD/Control/ID group):16.3/17.2/17 Kg/m2. |
|||
4. Vargason T et al. (America/Arizona: Caucasian; 2018: Research Autism Spectrum Disorder) |
64 (52/12; 11.8 ± 8.5y) |
49 (40/9; 12.2 ± 7.6y) |
ADOS/CARS | Plasma | GC/MS |
Twenty two plasma AAs and related amino acid metabolites were measured. ASD group: Increased level: glutamate, serine and hydroxyproline. |
RIAS: assess the IQ of ASD group children |
CARS | Nil |
1. Fasting overnight. 2. Age-sex matched. 3. ASD group: (45 children, 13 teens, 6 adults); Control group: (34 children, 10 teens, 5 adults). 4. 20 out of plasma AAs excluded for final analysis because of below the detection limit. |
|||
5. Zou M et al. (China/Harbin; Han; 2020;Neurotox Research) | 70 (62/8; 5.44 ± 1.36y) | 70 (62/8; 5.12 ± 0.79y) | DSM-5 | Plasma | LC-MS/MS |
Twenty one plasma AAs measured. 1. ASD group: Increased level: Arginine, cysteine, homocysteine, histidine, methionine, serine, tyrosine and valine. 2. Severity of autism: The level of homocysteine was positively correlated with the severity of autism. |
Nil | ADOS-CSS | Nil |
1. Standardized diet and moderate physical activity for one week. 2. Fasting blood samples. |
|||
6. Xing Y et al. (China /Guangzhou; Han; 2021; Psychiatry Research) | 60(49/11; 42.86 ± 11.03Mo) | 30(25/5; 39.32 ± 12.88Mo) | DSM-IV | Serum | TMS |
Twenty two serum AAs measured. 1. ASD group: 1) Increased level: asparagine. 2) Decreased level: lysine, tryptophan, phenylalanine, methionine, leucine, valine, threonine, glutamine, glycine, alanine, citrulline, cysteine, serine, tyrosine acid, and proline. 2. The serum glutamate/glutamine (Glu/Gln) ratio was elevated in the ASD PIQ ≥ 70 group. |
ASD group: 15 out of 60 children (3y and11Mo): assessed with C-WYCSI(FIQ: 48.0 ± 18.7; VIQ: 46.4 ± 12.9; PIQ: 58.8 ± 22.4). |
Nil | Nil |
1. BMI for each child. 2. Fast for 10 h. |
|||
7. Current research |
110(95/15; 3.22 ± 1.18y) |
55(45/10; 3.37 ± 1.23y) |
DSM-5/ADI-R/ADOS | Plasma | LC-MS/MS |
Forty eight plasma AAs measured and 43 plasma AAs analyzed. 1. ASD group: 1) Elevated level: glutamate, γ-Amino-n-butyric acid, glutamine, sarcosine, δ-Aminolevulinic acid, glycine and citrulline. 2) Decreased level: ethanolamine, phenylalanine, tryptophan, homocysteine, pyroglutamic acid, hydroxyproline, ornithine, histidine, lysine, and glutathione. 2. Severity of autism: The level of tryptophan distinct lower in severe group than in mild and moderate group. |
DQ/IQ: by GDDS/WISC-I V/WPPSI-IV): HFG: DQ/IQ ≥ 70 ;LFG: (DQ/IQ < 70) |
CARS: Severe autism: CARS score ≥ 36.5; mild and moderate autism: 30 ≤ CARS socre < 36.5 |
ASD group: Regressive group and Non-regressive group |
1. Fasting for 5-10 h. 2. Excluded vitamin B12 deficiency. 3. Age-sex matched. 4. 5 out of forty eight plasma AAs excluded due to below the detection limit. |
ABC: Autism Behavior Scale; ADI-R: Autism Diagnostic Interview Revised; ADOS: Autism Diagnostic Observation Scale; ASD: Autism Spectrum Disorder; ATEC : Autism Evaluation Treatment Checklist; BMI: Body Mass Index; CARS: Childhood Autism Rating Scale; CSS: Calibration Severity Score; C-WYCSI: Chinese-Wechsler Young Children Scale of Intelligence; DQ: Development Quotient; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders-IV; DSM-5: Diagnostic and Statistical Manual of Mental Disorders-5; FSIQ: Full Scale Intelligence Quotient; GC/MS: Gas Chromatography/Mass Spectrometry; GDDS: Gesell Development Diagnosis Scale; h: hour; HFG: High Functional Group; HPLC: High Performance Liquid Chromatography; ID: Intellectual Disability; LC-MS/MS: Liquid Chromatography-Tandem Mass Spectrometry; LFG: Low Functional Group; M: Mean; Mo: Month; PDD-BI: Pervasive Development Disorder-Behavior Inventory; PIQ: Performance Intelligence Quotient; RIAS: Reynolds Intelligence Assessment Scale; SAS: Severity of Autism Scale; SD: Standard Deviation; TMS:: Tandem Mass Spectrometry; VIQ: Verbal Intelligence Quotient; WISC-IV: Wechsler Intelligence Scale for Children-IV; WPPSI-IV: Wechsler Preschool and Primary Scale of Intelligence-IV; y: year